Diabetes technologies represent a paradigm shift in type 1 diabetes care. Continuous
subcutaneous insulin infusion (CSII) pumps and continuous glucose monitors (CGM) …

The role of automated insulin delivery systems in diabetes is expanding. Hybrid closed-loop
systems are being used in routine clinical practice for treating people with type 1 diabetes …

Context Minority young adults (YA) currently represent the largest growing population with
type 1 diabetes (T1D) and experience very poor outcomes. Modifiable drivers of disparities …

Background: Recent studies highlight racial–ethnic disparities in insulin pump and
continuous glucose monitor (CGM) use in people with type 1 diabetes (T1D), but drivers of …

OBJECTIVE To investigate glycemic and psychosocial outcomes with hybrid closed-loop
(HCL) versus user-determined insulin dosing with multiple daily injections (MDI) or insulin …

Background Automated insulin delivery is the treatment of choice in adults with type 1
diabetes. Data are needed on the efficacy and safety of automated insulin delivery for …

OBJECTIVE Recent studies highlight racial disparities in insulin pump (PUMP) and
continuous glucose monitor (CGM) use in children and adolescents with type 1 diabetes …

Objective: To evaluate changes in insulin pump use over two decades in a national US
sample. Research Design and Methods: We used data from the SEARCH for Diabetes in …

Aims To explore parents' experiences of using a hybrid closed-loop system (CamAPS FX)
when caring for a very young child (aged 1–7 years) with type 1 diabetes. Methods …

Aims: To explore healthcare professionals' views about the training and support needed to
rollout closed-loop technology to pregnant women with type 1 diabetes. Methods: We …